(en) M. Taylor, K. Mackay, J. Murphy, A. McIntosh, C. McIntosh, S. Anderson et K. Welch, « Quantifying the RR of harm to self and others from substance misuse: results from a survey of clinical experts across Scotland », BMJ Open, vol. 2, no 4, , e000774–e000774 (DOI10.1136/bmjopen-2011-000774, lire en ligne, consulté le )
cap-lyon.fr
vigitox.cap-lyon.fr
S. Courtin, « Ecstasy et grossesse », VIGItox, no 24, , p. 3 (lire en ligne)
Dunlap LE, Andrews AM & Olson DE « Dark classics in chemical neuroscience: 3,4-methylenedioxymethamphetamine » ACS Chem Neurosci. 2018;9(10):2408-2427. https://doi.org/10.1021/acschemneuro.8b00155
Renton RJ, Cowie JS & Oon MCH « A study of the precursors, intermediates and reaction by-products in the synthesis of 3,4-methylenedioxymethylamphetamine and its application to forensic drug analysis » Forensic Sci Internat. 1993;60(3):189-202. https://doi.org/10.1016/0379-0738(93)90238-6
Palhol F et al. « Impurity profiling of seized MDMA tablets by capillary gas chromatography » Anal Bioanal Chem. 2002;374(2):274–281. https://doi.org/10.1007/s00216-002-1477-6
Milhazes N et al. « Electrochemical and spectroscopic characterisation of amphetamine-like drugs: Application to the screening of 3,4-methylenedioxymethamphetamine (MDMA) and its synthetic precursors » Anal Chim Acta 2007;596(2):231-241. https://doi.org/10.1016/j.aca.2007.06.027
Gimeno P et al. « A study of impurities in intermediates and 3,4-methylenedioxymethamphetamine (MDMA) samples produced via reductive amination routes » Forensic Sci Internat. 2005;155(2-3):141-157. https://doi.org/10.1016/j.forsciint.2004.11.013
Gallagher R, Shimmon R & McDonagh AM « Synthesis and impurity profiling of MDMA prepared from commonly available starting materials » Forensic Sci Internat. 2012;223(1-3):306-313. https://doi.org/10.1016/j.forsciint.2012.10.006
Braun U, Shulgin AT & Braun G « Centrally active N-substituted analogs of 3,4-methylenedioxyphenylisopropylamine (3,4-methylenedioxyamphetamine) » J Phar Sci. 1980;69(2):192-195. https://doi.org/10.1002/jps.2600690220
Heather E, Shimmon R & McDonagh A « Organic impurity profiling of 3,4-methylenedioxymethamphetamine (MDMA) synthesised from catechol and eugenol via 4-allylcatechol » Forensic Sci Internat. 2020;309:110176. https://doi.org/10.1016/j.forsciint.2020.110176
Parker MA et al. « Synthesis and Pharmacological Evaluation of Ring-Methylated Derivatives of 3,4-(Methylenedioxy)amphetamine (MDA) » J Med Chem. 1998;41(6):1001-1005. https://doi.org/10.1021/jm9705925
dx.doi.org
(en) David Adam, « Origins of ecstasy an urban myth », Nature Reviews Drug Discovery, vol. 5, no 10, , p. 806–806 (ISSN1474-1784, DOI10.1038/nrd2172, lire en ligne, consulté le )
(en) S. Snelders et T. Pieters, « Speed in the Third Reich: Metamphetamine (Pervitin) Use and a Drug History From Below », Social History of Medicine, vol. 24, no 3, , p. 686–699 (ISSN0951-631X et 1477-4666, DOI10.1093/shm/hkq101, lire en ligne, consulté le )
Theodoridou A, Rowe AC, Penton-Voak IS, Rogers PJ, « Oxytocin and social perception: oxytocin increases perceived facial trustworthiness and attractiveness », Horm Behav, vol. 56, no 1, , p. 128–32 (PMID19344725, DOI10.1016/j.yhbeh.2009.03.019)
S. Parker Singleton, Julie B. Wang, Michael Mithoefer et Colleen Hanlon, « Altered brain activity and functional connectivity after MDMA-assisted therapy for post-traumatic stress disorder », Frontiers in Psychiatry, vol. 13, (ISSN1664-0640, DOI10.3389/fpsyt.2022.947622/full, lire en ligne, consulté le )
(en) M. Taylor, K. Mackay, J. Murphy, A. McIntosh, C. McIntosh, S. Anderson et K. Welch, « Quantifying the RR of harm to self and others from substance misuse: results from a survey of clinical experts across Scotland », BMJ Open, vol. 2, no 4, , e000774–e000774 (DOI10.1136/bmjopen-2011-000774, lire en ligne, consulté le )
George Hatzidimitriou, Una D. McCann et George A. Ricaurte, « Altered Serotonin Innervation Patterns in the Forebrain of Monkeys Treated with (±)3,4-Methylenedioxymethamphetamine Seven Years Previously: Factors Influencing Abnormal Recovery », The Journal of Neuroscience, vol. 19, no 12, , p. 5096–5107 (ISSN0270-6474, PMID10366642, PMCID6782677, DOI10.1523/JNEUROSCI.19-12-05096.1999, lire en ligne, consulté le )
Liechti, M., Gamma, A. et Vollenweider, F., Psychopharmacology (2001) 154: 161, DOI10.1007/s002130000648.
(en) Valerie H. Curran, « Sub-acute effects of MDMA (±3,4-methylenedioxymethamphetamine, ecstasy) on mood: evidence of gender differences », Psychopharmacology, Springer, vol. 161, no 1, , p. 23–31 (ISSN1432-2072, DOI10.1007/s00213-001-0995-9, lire en ligne, consulté le ).
S. Parker Singleton, Julie B. Wang, Michael Mithoefer et Colleen Hanlon, « Altered brain activity and functional connectivity after MDMA-assisted therapy for post-traumatic stress disorder », Frontiers in Psychiatry, vol. 13, (ISSN1664-0640, DOI10.3389/fpsyt.2022.947622/full, lire en ligne, consulté le )
inserm.fr
ipubli.inserm.fr
Présentation de l'ecstasy, détection et quantification, publication INSERM, lire en ligne.
S. Bernschneider-Reif, F. Oxler et R. W. Freudenmann, « The origin of MDMA ("ecstasy")--separating the facts from the myth », Die Pharmazie, vol. 61, no 11, , p. 966–972 (ISSN0031-7144, PMID17152992, lire en ligne, consulté le )
(en) David Adam, « Origins of ecstasy an urban myth », Nature Reviews Drug Discovery, vol. 5, no 10, , p. 806–806 (ISSN1474-1784, DOI10.1038/nrd2172, lire en ligne, consulté le )
(en) S. Snelders et T. Pieters, « Speed in the Third Reich: Metamphetamine (Pervitin) Use and a Drug History From Below », Social History of Medicine, vol. 24, no 3, , p. 686–699 (ISSN0951-631X et 1477-4666, DOI10.1093/shm/hkq101, lire en ligne, consulté le )
S. Parker Singleton, Julie B. Wang, Michael Mithoefer et Colleen Hanlon, « Altered brain activity and functional connectivity after MDMA-assisted therapy for post-traumatic stress disorder », Frontiers in Psychiatry, vol. 13, (ISSN1664-0640, DOI10.3389/fpsyt.2022.947622/full, lire en ligne, consulté le )
George Hatzidimitriou, Una D. McCann et George A. Ricaurte, « Altered Serotonin Innervation Patterns in the Forebrain of Monkeys Treated with (±)3,4-Methylenedioxymethamphetamine Seven Years Previously: Factors Influencing Abnormal Recovery », The Journal of Neuroscience, vol. 19, no 12, , p. 5096–5107 (ISSN0270-6474, PMID10366642, PMCID6782677, DOI10.1523/JNEUROSCI.19-12-05096.1999, lire en ligne, consulté le )
(en) Valerie H. Curran, « Sub-acute effects of MDMA (±3,4-methylenedioxymethamphetamine, ecstasy) on mood: evidence of gender differences », Psychopharmacology, Springer, vol. 161, no 1, , p. 23–31 (ISSN1432-2072, DOI10.1007/s00213-001-0995-9, lire en ligne, consulté le ).
Doblin, Rick. A Clinical Plan for MDMA (Ecstasy) in the Treatment of Post-Traumatic Stress Disorder (PTSD): Partnering with the FDA. Referenced 2011-10-23 from http://www.maps.org/news-letters/v12n3/12305dob.html
nature.com
(en) David Adam, « Origins of ecstasy an urban myth », Nature Reviews Drug Discovery, vol. 5, no 10, , p. 806–806 (ISSN1474-1784, DOI10.1038/nrd2172, lire en ligne, consulté le )
(en) Benzenhöfer U, « The early history of ecstasy », Nevenartz, (lire en ligne)
S. Bernschneider-Reif, F. Oxler et R. W. Freudenmann, « The origin of MDMA ("ecstasy")--separating the facts from the myth », Die Pharmazie, vol. 61, no 11, , p. 966–972 (ISSN0031-7144, PMID17152992, lire en ligne, consulté le )
Theodoridou A, Rowe AC, Penton-Voak IS, Rogers PJ, « Oxytocin and social perception: oxytocin increases perceived facial trustworthiness and attractiveness », Horm Behav, vol. 56, no 1, , p. 128–32 (PMID19344725, DOI10.1016/j.yhbeh.2009.03.019)
George Hatzidimitriou, Una D. McCann et George A. Ricaurte, « Altered Serotonin Innervation Patterns in the Forebrain of Monkeys Treated with (±)3,4-Methylenedioxymethamphetamine Seven Years Previously: Factors Influencing Abnormal Recovery », The Journal of Neuroscience, vol. 19, no 12, , p. 5096–5107 (ISSN0270-6474, PMID10366642, PMCID6782677, DOI10.1523/JNEUROSCI.19-12-05096.1999, lire en ligne, consulté le )
pubmed.ncbi.nlm.nih.gov
S. Bernschneider-Reif, F. Oxler et R. W. Freudenmann, « The origin of MDMA ("ecstasy")--separating the facts from the myth », Die Pharmazie, vol. 61, no 11, , p. 966–972 (ISSN0031-7144, PMID17152992, lire en ligne, consulté le )
(en) Laurent Galineau, « Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) exposure induces long-term alterations in the dopaminergic and serotonergic functions in the rat », Brain research. Developmental brain research., , p. 165-176 (lire en ligne).
(en) S. Snelders et T. Pieters, « Speed in the Third Reich: Metamphetamine (Pervitin) Use and a Drug History From Below », Social History of Medicine, vol. 24, no 3, , p. 686–699 (ISSN0951-631X et 1477-4666, DOI10.1093/shm/hkq101, lire en ligne, consulté le )
(en) Valerie H. Curran, « Sub-acute effects of MDMA (±3,4-methylenedioxymethamphetamine, ecstasy) on mood: evidence of gender differences », Psychopharmacology, Springer, vol. 161, no 1, , p. 23–31 (ISSN1432-2072, DOI10.1007/s00213-001-0995-9, lire en ligne, consulté le ).
Amine Benyamina et Isabelle de Paillette (préf. professeur Michel Reynaud), Réponses à vos questions sur le cannabis et les autres drogues, Paris, Solar, , 197 p. (ISBN978-2-263-03904-1, OCLC62609834)
(en) Yasmina Salmandjee, Les drogues : Tout savoir sur leurs effets, leurs risques et la législation, Eyrolles, coll. « Eyrolles Pratique », , 223 p. (ISBN978-2-7081-3532-1, OCLC181336267)
